The first method to combine tissue clearing and proteomics allows researchers to peer into tissues to find early markers of disease. By making tissues almost transparent, researchers can then reach in ...
On February 28, Amgen, Inc. (“Amgen”) filed three petitions for inter partes review, challenging the validity of all claims in three patents assigned to Bristol-Myers Squibb Co. (“BMS”). The claims of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results